TransMedics Group, Inc. Stock price
Equities
TMDX
US89377M1099
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
73.94 USD | -0.24% | -0.05% | -6.32% |
Financials (USD)
Sales 2024 * | 367M | Sales 2025 * | 490M | Capitalization | 2.42B |
---|---|---|---|---|---|
Net income 2024 * | -1M | Net income 2025 * | 16M | EV / Sales 2024 * | 7.11 x |
Net Debt 2024 * | 188M | Net Debt 2025 * | 205M | EV / Sales 2025 * | 5.35 x |
P/E ratio 2024 * |
-1,043
x | P/E ratio 2025 * |
165
x | Employees | 584 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.36% |
Latest transcript on TransMedics Group, Inc.
1 day | -0.24% | ||
1 week | -0.05% | ||
Current month | -9.39% | ||
1 month | -9.83% | ||
3 months | -8.81% | ||
6 months | +30.24% | ||
Current year | -6.32% |
Managers | Title | Age | Since |
---|---|---|---|
Waleed Hassanein
FOU | Founder | 55 | 98-07-31 |
Stephen Gordon
DFI | Director of Finance/CFO | 56 | 15-02-28 |
Mark Anderson
CTO | Chief Tech/Sci/R&D Officer | - | 06-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
James Tobin
CHM | Chairman | 79 | 10-12-31 |
Ed Kania
BRD | Director/Board Member | 67 | 02-12-31 |
Merilee Raines
BRD | Director/Board Member | 68 | 20-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.20% | 12 M€ | -.--% | - | |
0.09% | 227 M€ | +5.31% | - | |
0.03% | 735 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 73.94 | -0.24% | 877,709 |
24-03-27 | 74.12 | -0.50% | 596,098 |
24-03-26 | 74.49 | +4.81% | 813,387 |
24-03-25 | 71.07 | +0.30% | 708,641 |
24-03-22 | 70.86 | -4.22% | 993,239 |
Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.32% | 2.42B | |
+9.50% | 222B | |
+7.95% | 185B | |
+18.30% | 141B | |
+18.47% | 100B | |
+7.83% | 68.36B | |
+25.32% | 57.52B | |
-3.69% | 46.84B | |
+4.66% | 42.64B | |
+15.12% | 29.09B |